U.S. markets open in 4 hours 13 minutes
  • S&P Futures

    3,829.75
    +4.25 (+0.11%)
     
  • Dow Futures

    30,978.00
    +45.00 (+0.15%)
     
  • Nasdaq Futures

    11,689.00
    +14.75 (+0.13%)
     
  • Russell 2000 Futures

    1,739.80
    +1.50 (+0.09%)
     
  • Crude Oil

    111.75
    -0.01 (-0.01%)
     
  • Gold

    1,818.20
    -3.00 (-0.16%)
     
  • Silver

    20.75
    -0.06 (-0.27%)
     
  • EUR/USD

    1.0526
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    3.2060
    0.0000 (0.00%)
     
  • Vix

    28.58
    +1.63 (+6.05%)
     
  • GBP/USD

    1.2188
    +0.0003 (+0.03%)
     
  • USD/JPY

    136.1300
    +0.0020 (+0.00%)
     
  • BTC-USD

    20,088.56
    -1,066.19 (-5.04%)
     
  • CMC Crypto 200

    434.96
    -15.10 (-3.35%)
     
  • FTSE 100

    7,288.65
    -34.76 (-0.47%)
     
  • Nikkei 225

    26,804.60
    -244.87 (-0.91%)
     

FDA Roundup: June 17, 2022

·2 min read

SILVER SPRING, Md., June 17, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

  • On Thursday, the FDA's National Center for Toxicological Research (NCTR) announced the publication of three International Test Method Standards in Nanotechnology by the American Society for Testing and Materials (ASTM) International. NCTR scientists conducted research with support from the National Institute of Environmental Health Sciences (NIEHS) toward the collaborative consensus-standards development for liposomes. These standards will increase predictability, streamline pre-market review, and facilitate new product entry to market.

  • The FDA has sent to Congress its Report on Drug Shortages for Calendar Year 2021, the ninth annual report to summarize major actions taken by the agency to prevent or mitigate drug shortages in the United States. While the number of new drug shortages has declined over the years, 2021 was a challenging year for shortages as manufacturers in the U.S. and abroad continue to experience quality issues and capacity constraints. Even still, the agency made important progress in helping to mitigate drug shortages. During CY 2021, there were 41 new shortages, and the FDA helped prevent 317 potential shortages.

  • COVID-19 testing updates:

Additional Resources:

Media Contact: FDA Office of Media Affairs, 301-796-4540 
Consumer Inquiries: 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

U.S. Food and Drug Administration (FDA) logo (PRNewsfoto/FDA)
U.S. Food and Drug Administration (FDA) logo (PRNewsfoto/FDA)

 

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/fda-roundup-june-17-2022-301570553.html

SOURCE U.S. Food and Drug Administration